IL149337A0 - Phenoxy carboxylic acid compounds and compositions for delivering active agents - Google Patents

Phenoxy carboxylic acid compounds and compositions for delivering active agents

Info

Publication number
IL149337A0
IL149337A0 IL14933700A IL14933700A IL149337A0 IL 149337 A0 IL149337 A0 IL 149337A0 IL 14933700 A IL14933700 A IL 14933700A IL 14933700 A IL14933700 A IL 14933700A IL 149337 A0 IL149337 A0 IL 149337A0
Authority
IL
Israel
Prior art keywords
compositions
carboxylic acid
active agents
acid compounds
phenoxy carboxylic
Prior art date
Application number
IL14933700A
Other languages
English (en)
Original Assignee
Emisphere Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emisphere Tech Inc filed Critical Emisphere Tech Inc
Publication of IL149337A0 publication Critical patent/IL149337A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
    • C07C65/24—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/18—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C229/56—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in ortho-position
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/92—Unsaturated compounds containing keto groups containing —CHO groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/32—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups
    • C07C65/40—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups containing singly bound oxygen-containing groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL14933700A 1999-11-05 2000-11-06 Phenoxy carboxylic acid compounds and compositions for delivering active agents IL149337A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US16380699P 1999-11-05 1999-11-05
US23183600P 2000-09-06 2000-09-06
US23723300P 2000-10-02 2000-10-02
PCT/US2000/030662 WO2001032596A1 (en) 1999-11-05 2000-11-06 Phenoxy carboxylic acid compounds and compositions for delivering active agents

Publications (1)

Publication Number Publication Date
IL149337A0 true IL149337A0 (en) 2002-11-10

Family

ID=27388931

Family Applications (4)

Application Number Title Priority Date Filing Date
IL14933700A IL149337A0 (en) 1999-11-05 2000-11-06 Phenoxy carboxylic acid compounds and compositions for delivering active agents
IL14933600A IL149336A0 (en) 1999-11-05 2000-11-06 Phenyl amine carboxylic acid compounds and compositions for delivering active agents
IL149337A IL149337A (en) 1999-11-05 2002-04-24 Carboxylic acid components and compounds for the transfer of active carriers
IL195055A IL195055A (en) 1999-11-05 2008-11-02 Carboxylic acid components and compounds for transporting active carriers

Family Applications After (3)

Application Number Title Priority Date Filing Date
IL14933600A IL149336A0 (en) 1999-11-05 2000-11-06 Phenyl amine carboxylic acid compounds and compositions for delivering active agents
IL149337A IL149337A (en) 1999-11-05 2002-04-24 Carboxylic acid components and compounds for the transfer of active carriers
IL195055A IL195055A (en) 1999-11-05 2008-11-02 Carboxylic acid components and compounds for transporting active carriers

Country Status (17)

Country Link
EP (2) EP1226104B1 (cs)
JP (2) JP5117658B2 (cs)
KR (1) KR100788970B1 (cs)
CN (1) CN1384814B (cs)
AT (1) ATE427925T1 (cs)
AU (3) AU2622301A (cs)
BR (1) BRPI0015567B8 (cs)
CA (2) CA2388240C (cs)
CZ (2) CZ20021570A3 (cs)
DE (1) DE60041976D1 (cs)
HK (1) HK1048801B (cs)
HU (1) HU229415B1 (cs)
IL (4) IL149337A0 (cs)
MX (2) MXPA02004451A (cs)
NZ (1) NZ530450A (cs)
PL (1) PL201505B1 (cs)
WO (2) WO2001032596A1 (cs)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6916489B2 (en) 1992-06-15 2005-07-12 Emisphere Technologies, Inc. Active agent transport systems
US6461643B2 (en) 1993-04-22 2002-10-08 Emisphere Technologies, Inc. Oral drug delivery compositions and methods
SI9720025A (sl) 1996-03-29 1999-08-31 Emishphere Technologies, Inc. Spojine in sestavki za prenos aktivne snovi
US6991798B1 (en) 1998-08-07 2006-01-31 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
CZ302280B6 (cs) 1998-08-07 2011-01-26 Emisphere Technologies, Inc. Slouceniny a prostredky pro dodávání aktivních látek
AU2001236457A1 (en) 2000-01-13 2001-07-24 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
WO2003057650A2 (en) 2002-01-09 2003-07-17 Emisphere Technologies, Inc. Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoate
NZ523017A (en) 2000-06-29 2004-10-29 Emisphere Tech Inc Compounds and compositions for delivering active agents and preparation method thereof
DE60138468D1 (de) * 2000-09-06 2009-06-04 Emisphere Tech Inc Cyanophenoxy-carbonsäuren und zusammensetzungen für die freisetzung aktiver substanzen
CN1492763B (zh) * 2001-03-01 2012-05-23 艾米斯菲尔技术有限公司 用于递送二膦酸盐的组合物
CN100516020C (zh) 2001-09-26 2009-07-22 艾米斯菲尔技术有限公司 通过二羧化物中间体制备苯氧基链烷酸、链烯酸和炔酸及其盐的方法
NZ532597A (en) * 2001-11-13 2006-04-28 Emisphere Tech Inc Phenoxy amine compounds and compositions for delivering active agents
AU2002352974A1 (en) 2001-11-29 2003-06-10 Emisphere Technologies, Inc. Formulations for oral administration of cromolyn sodium
WO2003072195A2 (en) 2002-02-20 2003-09-04 Eli Lilly And Company Method for administering glp-1 molecules
NZ543274A (en) * 2003-05-14 2007-12-21 Emisphere Tech Inc Compositions for delivering peptide YY and PYY agonists
AU2004267044B8 (en) 2003-08-20 2009-12-17 Emisphere Technologies, Inc. Compounds, methods and formulations for the oral delivery of a glucagon like peptide (GLP)-1 compound or an melanocortin 4 receptor (MC4) agonist peptide
ES2278346T3 (es) 2003-08-20 2007-08-01 Eli Lilly And Company Compuestos, procedimientos y formulaciones para suministro oral de un compuesto peptido (glp)-1 del tipo de glucagon o un peptido agonista (glp)-4 del receptor 4 de melacortina (mc4).
US20060286129A1 (en) 2003-12-19 2006-12-21 Emisphere Technologies, Inc. Oral GLP-1 formulations
US7217703B2 (en) 2004-04-16 2007-05-15 Emisphere Technologies, Inc. 8-(2-hydroxyphenoxy)octyldiethanolamine and salts thereof for delivery of active agents
US8039018B2 (en) 2004-05-06 2011-10-18 Emisphere Technologies, Inc. Solid dosage form of wetted heparin
RU2403237C2 (ru) * 2004-05-14 2010-11-10 Эмисфире Текнолоджис, Инк. Составы и смеси для доставки активных агентов
MXPA06013251A (es) 2004-05-14 2007-02-28 Emisphere Tech Inc Compuestos y composiciones de aril-cetona para suministrar agentes activos.
JP5254610B2 (ja) 2004-05-14 2013-08-07 エミスフェアー・テクノロジーズ・インク 活性薬剤を送達するための化合物および組成物
RU2406504C2 (ru) 2004-05-19 2010-12-20 Эмисфире Текнолоджис, Инк. Способы изготовления лекарственных составов ацикловира
US9498487B2 (en) 2004-05-19 2016-11-22 Emisphere Technologies, Inc. Topical cromolyn formulations
EP1791553B1 (en) * 2004-07-12 2013-10-23 Emisphere Technologies, Inc. Compositions for delivering peptide yy and pyy agonists
WO2006017541A2 (en) 2004-08-03 2006-02-16 Emisphere Technologies, Inc. Antidiabetic oral insulin-biguanide combination
JP2008509933A (ja) * 2004-08-13 2008-04-03 エミスフェアー・テクノロジーズ・インク 送達剤のマイクロ粒子またはナノ粒子を含む医薬製剤
CA2591515C (en) 2004-12-29 2010-06-22 Emisphere Technologies, Inc. Pharmaceutical formulations of gallium salts
US8110547B2 (en) 2005-01-12 2012-02-07 Emisphere Technologies, Inc. Compositions for buccal delivery of parathyroid hormone
FR2880887B1 (fr) * 2005-01-14 2009-01-30 Merck Sante Soc Par Actions Si Derives d'hydroxyphenols, procedes pour leur preparation, compositions pharmaceutiques les contenant et applications en therapeutique
US8975227B2 (en) 2005-07-15 2015-03-10 Emisphere Technologies, Inc. Intraoral dosage forms of glucagon
US8927015B2 (en) 2006-04-12 2015-01-06 Emisphere Technologies, Inc. Formulations for delivering insulin
ES2538254T3 (es) * 2006-04-18 2015-06-18 Emisphere Technologies, Inc. Agentes de administración de dialquil éter
US8771712B2 (en) 2006-05-09 2014-07-08 Emisphere Technologies, Inc. Topical administration of acyclovir
WO2008003050A2 (en) 2006-06-28 2008-01-03 Emisphere Technologies, Inc. Gallium nitrate formulations
JP5564255B2 (ja) 2006-08-18 2014-07-30 エミスフェアー・テクノロジーズ・インク プロピルフェノキシエーテルの合成および送達剤としての使用
JP5577094B2 (ja) * 2006-08-31 2014-08-20 エミスフェアー・テクノロジーズ・インク 活性薬剤を送達するための化合物及び組成物
US20110046050A1 (en) 2007-02-08 2011-02-24 Emisphere Technologies, Inc. Phenylalkylcarboxylic acid delivery agents
ES2579229T3 (es) 2007-03-13 2016-08-08 Jds Therapeutics, Llc Procedimientos y composiciones para la liberación sostenida de cromo
WO2009002867A2 (en) 2007-06-26 2008-12-31 Nutrition 21, Inc. Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
JP5985985B2 (ja) 2009-08-03 2016-09-06 エミスフィアー テクノロジーズ インコーポレイテッドＥｍｉｓｐｈｅｒｅ Ｔｅｃｈｎｏｌｏｇｉｅｓ，Ｉｎｃ． 胃腸への影響が減少した即効型ナプロキセン組成物
WO2011097148A2 (en) * 2010-02-04 2011-08-11 Parsons Lowell C Use of oral heparin preparations to treat urinary tract diseases and conditions
EP2680861B1 (en) 2011-03-01 2022-05-04 Nutrition 21, LLC Compositions of insulin and chromium for the treatment and prevention of diabetes, hypoglycemia and related disorders
EA023447B1 (ru) * 2011-12-28 2016-06-30 Борис Славинович ФАРБЕР Производное инсулина, обладающее сахароснижающей активностью при пероральном применении, способ его получения и лекарственные формы на его основе
SG10201702513SA (en) * 2011-12-28 2017-05-30 Univ California Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation
EP2797597B1 (en) 2011-12-28 2020-02-26 Global Blood Therapeutics, Inc. Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation
CA2882719C (en) 2012-08-23 2021-01-26 Emisphere Technologies, Inc. Phenoxy alkyl diethanolamine and diisopropanolamine compounds for delivering active agents
US10266551B2 (en) 2013-03-15 2019-04-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9422279B2 (en) 2013-03-15 2016-08-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
WO2014145040A1 (en) 2013-03-15 2014-09-18 Global Blood Therapeutics, Inc. Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
US20160083343A1 (en) 2013-03-15 2016-03-24 Global Blood Therapeutics, Inc Compounds and uses thereof for the modulation of hemoglobin
US9458139B2 (en) 2013-03-15 2016-10-04 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
ES2890077T3 (es) 2013-03-15 2022-01-17 Global Blood Therapeutics Inc Compuestos y usos de los mismos para la modulación de la hemoglobina
US8952171B2 (en) 2013-03-15 2015-02-10 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
PE20160078A1 (es) 2013-03-15 2016-03-02 Global Blood Therapeutics Inc Compuestos y sus usos para modular la hemoglobina
EA201992707A1 (ru) 2013-11-18 2020-06-30 Глобал Блад Терапьютикс, Инк. Соединения и их применения для модуляции гемоглобина
MX361810B (es) 2014-02-07 2018-12-14 Global Blood Therapeutics Inc Polimorfos cristalinos de la base libre de 2-hidroxi-6-((2-(1-isop ropil-1h-pirazol-5-il-)piridin-3-il)metoxi)benzaldehido.
WO2016128972A1 (en) 2015-02-09 2016-08-18 Entera Bio Ltd. Formulations for oral administration of active agents with controlled absorption profile
MA43373A (fr) 2015-12-04 2018-10-10 Global Blood Therapeutics Inc Régimes posologiques pour 2-hydroxy-6-((2- (1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)méthoxy)benzaldéhyde
GB2564295A (en) 2016-02-11 2019-01-09 Nutrition 21 Llc Chromium containing compositions for improving health and fitness
TWI825524B (zh) 2016-05-12 2023-12-11 美商全球血液治療公司 用於合成2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)-吡啶-3-基)甲氧基)苯甲醛之方法
KR102832566B1 (ko) 2016-08-17 2025-07-09 엔테라 바이오 리미티드 활성 물질의 경구 투여용 제형
TWI778983B (zh) 2016-10-12 2022-10-01 美商全球血液治療公司 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
US11014884B2 (en) 2018-10-01 2021-05-25 Global Blood Therapeutics, Inc. Modulators of hemoglobin

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2375138A (en) * 1942-05-01 1945-05-01 American Cyanamid Co Alkamine esters of aryloxymethyl benzoic acid
NL133069C (cs) * 1966-07-29
JPS55145648A (en) * 1979-05-02 1980-11-13 Hisamitsu Pharmaceut Co Inc New derivative of anthranylic acid
AU545274B2 (en) * 1979-06-29 1985-07-11 Wellcome Foundation Limited, The 5-(2-formyl-3-hydroxyphenoxy) - pentanoic acid derivatives
JPS5750946A (en) * 1980-09-10 1982-03-25 Hisamitsu Pharmaceut Co Inc Novel anthranilic acid derivative
DE3206030A1 (de) * 1981-02-19 1982-09-09 Fuji Photo Film Co., Ltd., Minami-Ashigara, Kanagawa Verfahren zur bildung von polymeren bildern und druckplatten
US4499299A (en) * 1981-12-30 1985-02-12 Ici Americas Inc. Pharmaceutically active phenylcarboxylic acid derivatives
JPS58142901A (ja) * 1982-02-19 1983-08-25 Nippon Zeon Co Ltd ゴムの変性方法
JPH0245481A (ja) * 1988-08-03 1990-02-15 Yamamura Kagaku Kenkyusho:Kk クマラン化合物の製造法
DE4142514A1 (de) * 1991-12-21 1993-06-24 Basf Ag Verfahren zur bekaempfung von pilzen
FR2687316B3 (fr) * 1992-02-13 1994-08-12 Rolland Sa A Nouvelle utilisation de compositions pharmaceutiques a base de derives phenoxyacetiques en vue de la restauration des fonctions nerveuses.
IL104283A (en) * 1992-12-30 1996-12-05 Agis Ind 1983 Ltd Non-emulsion antiviral topical pharmaceutical composition comprising acyclovir an aqueous gel agent and an alkali oleate
US5364767A (en) * 1993-02-11 1994-11-15 Research Organics, In. Chromogenic compounds and methods of using same
FR2710782A1 (fr) * 1993-09-29 1995-04-07 Sodern Tube neutronique à confinement magnétique des électrons par aimants permanents et son procédé de fabrication.
US5837702A (en) * 1993-10-07 1998-11-17 Bristol-Myers Squibb Co. 4-arylamino-benzopyran and related compounds
TW270114B (cs) * 1993-10-22 1996-02-11 Hoffmann La Roche
US5783593A (en) * 1993-11-04 1998-07-21 Abbott Laboratories Inhibitors of squalene synthetase and protein farnesyltransferase
US5650386A (en) * 1995-03-31 1997-07-22 Emisphere Technologies, Inc. Compositions for oral delivery of active agents
US5824638A (en) * 1995-05-22 1998-10-20 Shire Laboratories, Inc. Oral insulin delivery
US5747537A (en) * 1995-09-05 1998-05-05 Washington University Method of inhibiting parasitic activity
JPH09207543A (ja) * 1996-02-08 1997-08-12 Denso Corp 空調装置
JP2001527517A (ja) * 1996-07-26 2001-12-25 スーザン・ピー・ペリーネ 血液、ウイルス性および細胞性疾患の治療組成物
EP0935523B1 (en) * 1996-10-28 2004-09-29 Inc. General Mills Embedding and encapsulation of controlled release particles
EP1049459B1 (en) * 1998-01-20 2009-04-22 Applied Analytical Industries, Inc. Oral liquid compositions

Also Published As

Publication number Publication date
EP1226104A1 (en) 2002-07-31
JP2003513060A (ja) 2003-04-08
EP1226104B1 (en) 2009-04-08
AU2622301A (en) 2001-05-14
HU229415B1 (en) 2013-12-30
JP5117658B2 (ja) 2013-01-16
WO2001032596A1 (en) 2001-05-10
IL195055A (en) 2015-07-30
AU2005248960B2 (en) 2009-01-29
PL354996A1 (en) 2004-03-22
CN1384814A (zh) 2002-12-11
EP1226109A2 (en) 2002-07-31
PL201505B1 (pl) 2009-04-30
HK1048801B (en) 2009-08-28
WO2001032130A2 (en) 2001-05-10
IL149337A (en) 2010-04-15
MXPA02004092A (es) 2003-02-12
BRPI0015567B1 (pt) 2016-10-25
BRPI0015567B8 (pt) 2021-05-25
EP1226109A4 (en) 2005-01-26
IL149336A0 (en) 2002-11-10
WO2001032130A3 (en) 2002-03-14
KR100788970B1 (ko) 2007-12-27
HK1048801A1 (en) 2003-04-17
MXPA02004451A (es) 2002-10-23
BR0015567A (pt) 2002-07-16
CZ20021570A3 (cs) 2002-10-16
ATE427925T1 (de) 2009-04-15
CA2390025A1 (en) 2001-05-10
CA2388240A1 (en) 2001-05-10
AU2005248960A1 (en) 2006-02-02
WO2001032596A8 (en) 2001-08-09
IL195055A0 (en) 2009-08-03
HUP0600033A2 (en) 2006-08-28
CZ20021554A3 (cs) 2002-10-16
CN1384814B (zh) 2015-11-25
DE60041976D1 (de) 2009-05-20
NZ530450A (en) 2004-06-25
KR20020060222A (ko) 2002-07-16
JP2004501057A (ja) 2004-01-15
AU783157B2 (en) 2005-09-29
CA2388240C (en) 2010-04-20
EP1226104A4 (en) 2005-05-04
AU1655401A (en) 2001-05-14

Similar Documents

Publication Publication Date Title
IL195055A0 (en) Phenoxy carboxylic acid compounds and compositions for delivering active agents
MXPA01008611A (es) Compuestos y composiciones para suministrar agentes activos.
AU2274201A (en) Compounds and compositions for delivering active agents
PL347671A1 (en) Compounds and compositions for delivering active agents
AU7315301A (en) Compounds and compositions for delivering active agents
NZ524138A (en) Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents
MXPA04004567A (es) Compuestos y composiciones de fenoxi amina para adminstrar agentes activos.
AU3492100A (en) Oxadiazole compounds and compositions for delivering active agents
MXPA03007857A (es) Compuestos y composiciones para entregar agentes activos.
EP1093819A3 (en) Compounds and compositions for delivering active agents
CA2338358A1 (en) Compounds and compositions for delivering active agents
AU2001296865A1 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
CA2203033A1 (en) Compounds and compositions for delivering active agents
MXPA03007837A (es) Composiciones para suministrar bisfosfonatos.
WO2002015959A3 (en) Compounds and compositions for delivering active agents
UA66812C2 (uk) Препаративна форма лікарського засобу із регульованим вивільненням активної речовини
WO2002100338A3 (en) Compound and composition for delivering active agents
WO2005062874A3 (en) Compounds and compositions for delivering active agents
EP1676832A3 (en) Compounds and compositions for delivering active agents